Warenkorb -  AGBs -  Datenschutz -  Contact us   

 

Explode tree
Collapse tree

Test.


Hybrid Cardiac Imaging


NEKOLLA / RISCHPLER --- Neuerscheinung!!

Hybrid Cardiac Imaging

309 Seiten, 1. Auflage, 2022
106 Abbildungen

  • Reviews all clinically relevant hybrid imaging modalities: SPECT/CT, PET/CT, and PET/MRI
  • Discusses applications, instrumentation, protocols, peculiarities, and economic aspects
  • Considers the role of novel imaging probes
This clinically oriented book provides an up-to-date review on the various hybrid imaging modalities that may be employed for the purpose of cardiac imaging. After discussion of generic aspects of hybrid imaging, SPECT/CT, PET/CT, and PET/MRI are each considered in depth.

In addition, information is provided on upcoming technologies, such as dedicated so-called fast cardiac cameras (CZT detector technology) and novel probes and radiotracers. A wide variety of topics are addressed, including important technological aspects, possible applications, imaging protocols, peculiarities of the available modalities, radiation exposure, and dose reduction. Last but not least, an estimation of the cost efficiency of dedicated and hybrid imaging devices in cardiology is provided and possible scenarios with respect to health care economics are envisioned.

Hybrid Cardiac Imaging will be of particular value for nuclear medicine specialists, cardiologists, and radiologists and will also be of interest to medical physicists, medical technicians, and cardiothoracic surgeons.

Table of Contents

PART I Generic aspects of hybrid imaging
  • 1 Hybrid imaging and health care economics
  • 2 Hybrid imaging and radiation exposure
  • 3 Industry perspective
  • 4 Global/regional peculiarities
PART II SPECT/CT
  • 5 Perfusion, Calcium Scoring, and CTA
  • 6 Innervation/Intervention
  • 7 Novel techniques: solid state detectors , dose reduction
PART III PET/CT
  • 8 Perfusion, flow quantification, FFR
  • 9 Viability
  • 10 Inflammation
  • 11 Novel CT technology
  • 12 Novel PET tracers
PART IV PET/MR
  • 12 Perfusion and viability
  • 13 Inflammation
  • 14 Novel MR technology

€ 149,79
   
versandkostenfrei - in acht bis zehn Werktagen lieferbar Anzahl:
Preis: € 149,79